insights_auto
Why is INO up ५.४८%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ ०.८४
arrow_upward
+५.४८%(+०.०४४) 1D
US$ ०.८५
arrow_upward
+१.३२% (+०.०११)bedtimeAfter hours
Closed: अक्टोबर २२, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ ०.८०
High
US$ ०.९२
Low
US$ ०.७८
Mkt. cap
८.६२ करोड
Avg. vol.
३३.८९ लाख
Volume
०.००
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
Open
US$ ०.८०
High
US$ ०.९२
Low
US$ ०.७८
Mkt. cap
८.६२ करोड
Avg. vol.
३३.८९ लाख
Volume
०.००
52-wk high
US$ २.७२
52-wk low
US$ ०.५७
EPS
-US$ १.१७
Beta
१.६१
Shares outstanding
१०.३४ करोड
No. of employees
११२
News stories
From web sources and news partners
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc